Imagion Biosystems Limited (ASX:IBX)
Imagion Biosystems (ASX:IBX) is developing a new non-radioactive and safe diagnostic imaging technology. Its purpose is to find and eliminate cancer. Treatments are more successful and survival rates improve with early detection. By combining high sensitivity imaging technologies with nanoparticle technology, the company aims to make the detection of diseases like cancer better and safer for patients as well as provide new methods for therapeutic intervention.
Imagion Biosystems listed on the Australian Securities Exchange (ASX) in June 2017.